theory clinical_47_9
imports Main

begin

typedecl entity
typedecl event

consts
  PARPInhibitors :: "entity ⇒ bool"
  PARP :: "entity ⇒ bool"
  DSBs :: "entity ⇒ bool"
  SSBreakRepair :: "entity ⇒ bool"
  Function :: "event ⇒ bool"
  Inhibit :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Prevent :: "event ⇒ bool"
  LeadTo :: "event ⇒ bool"
  CollapsedReplicationForks :: "event ⇒ bool"
  RelianceOnErrorProneNHEJ :: "event ⇒ bool"
  LossOfBRCA2 :: "entity ⇒ bool"
  CancerDevelopment :: "entity ⇒ bool"
  GenomicInstability :: "entity ⇒ bool"
  Drive :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  Involve :: "event ⇒ bool"
  DefectiveHRR :: "event ⇒ bool"
  TrappingOfPARP1 :: "entity ⇒ bool"
  NHEJ :: "entity ⇒ bool"
  Increase :: "event ⇒ bool"
  Toxicity :: "event ⇒ bool"
  Indicate :: "event ⇒ bool"
  InhibitionOfPARP :: "entity ⇒ bool"
  Contribute :: "event ⇒ bool"
  ErrorProneNHEJ :: "event ⇒ bool"
  RelyOn :: "event ⇒ bool"

(* Explanation 1: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks and reliance on error-prone non-homologous end joining for DNA repair *)
axiomatization where
  explanation_1: "∃x y z w e1 e2 e3 e4 e5. PARPInhibitors x ∧ PARP y ∧ DSBs z ∧ SSBreakRepair w ∧ Function e1 ∧ Agent e1 x ∧ Inhibit e2 ∧ Agent e2 x ∧ Patient e2 y ∧ Cause e3 ∧ Agent e3 y ∧ Patient e3 z ∧ Prevent e4 ∧ Agent e4 y ∧ Patient e4 w ∧ LeadTo e5 ∧ CollapsedReplicationForks e5 ∧ RelianceOnErrorProneNHEJ e5"

(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair *)
axiomatization where
  explanation_2: "∃x y z e1 e2. LossOfBRCA2 x ∧ CancerDevelopment y ∧ GenomicInstability z ∧ Drive e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Via e1 z ∧ Involve e2 ∧ Agent e2 z ∧ DefectiveHRR e2"

(* Explanation 3: Trapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair *)
axiomatization where
  explanation_3: "∃x y z e1 e2 e3. TrappingOfPARP1 x ∧ DSBs y ∧ NHEJ z ∧ Increase e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Toxicity e2 ∧ Increase e2 ∧ Agent e2 x ∧ Indicate e3 ∧ RelianceOnErrorProneNHEJ e3"

(* Explanation 4: The inhibition of PARP by PARP inhibitors directly leads to the occurrence of double-strand breaks and prevents single-strand break repair, which contributes to defective homologous recombination repair *)
axiomatization where
  explanation_4: "∃x y z w e1 e2 e3. InhibitionOfPARP x ∧ PARPInhibitors y ∧ DSBs z ∧ SSBreakRepair w ∧ LeadTo e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 w ∧ Contribute e3 ∧ DefectiveHRR e3"

theorem hypothesis:
  assumes asm: "PARPInhibitors x"
  (* Hypothesis: PARP inhibitors cause replication‐associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA *)
  shows "∃x y z e1 e2 e3. PARPInhibitors x ∧ DSBs y ∧ SSBreakRepair z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 z ∧ RelyOn e3 ∧ Agent e3 x ∧ DefectiveHRR e3 ∧ ErrorProneNHEJ e3"
proof -
  (* From the premise, we have the known information about PARP inhibitors. *)
  from asm have "PARPInhibitors x" by auto
  (* There is a logical relation Implies(A, B), Implies(PARP inhibitors inhibit PARP, double-strand breaks occur) *)
  (* From explanation 1, we know that PARP inhibitors inhibit PARP, which causes double-strand breaks. *)
  then have "DSBs y" sledgehammer
  (* There is a logical relation Implies(A, C), Implies(PARP inhibitors inhibit PARP, single-strand break repair is prevented) *)
  (* From explanation 1, we know that PARP inhibitors inhibit PARP, which prevents single-strand break repair. *)
  then have "SSBreakRepair z" <ATP>
  (* There is a logical relation Implies(A, I), Implies(PARP inhibitors inhibit PARP, defective homologous recombination repair) *)
  (* From explanation 4, we know that inhibition of PARP by PARP inhibitors contributes to defective homologous recombination repair. *)
  then have "DefectiveHRR e3" <ATP>
  (* There is a logical relation Implies(A, E), Implies(PARP inhibitors inhibit PARP, reliance on error-prone non-homologous end joining for DNA repair) *)
  (* From explanation 1, we know that PARP inhibitors lead to reliance on error-prone non-homologous end joining for DNA repair. *)
  then have "ErrorProneNHEJ e3" <ATP>
  (* Combine all the derived information to show the hypothesis. *)
  then show ?thesis <ATP>
qed

end
